Melanoma Tumors Use Interferon-Gamma Mutations to Fight Immunotherapy
University of Texas MD Anderson Cancer CenterMelanoma tumors use genetic mutations in a prominent immune response pathway to resist the immunotherapy ipilimumab, researchers from The University of Texas MD Anderson Cancer Center report in the journal Cell.